Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MDWD
MDWD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MDWD News
U.S. Expert Consensus Supports MediWound's Chronic Wound Treatment Strategy
Apr 13 2026
Newsfilter
MediWound Reports $197 Million BARDA Contract Award to Vericel for NexoBrid
Apr 02 2026
Newsfilter
MediWound Ltd. Q4 2025 Earnings Call Insights
Mar 05 2026
seekingalpha
MediWound Files Annual Report for FY2025
Mar 05 2026
Newsfilter
MediWound Q4 Earnings Beat Expectations Despite Revenue Decline
Mar 05 2026
seekingalpha
MediWound to Announce Q4 Earnings on March 5
Mar 04 2026
seekingalpha
MediWound Reports NexoBrid Reduces Traumatic Tattoo Risk by 92.5%
Dec 10 2025
Globenewswire
MediWound Reports NexoBrid's 92.5% Effectiveness in Preventing Traumatic Tattoos
Dec 10 2025
Newsfilter
Palo Alto Set to Surge by 30%? Check Out 10 Leading Analyst Predictions for Friday
Nov 21 2025
Benzinga
HC Wainwright & Co. Reaffirms Buy Rating for MediWound, Increases Price Target to $36
Nov 21 2025
Benzinga
MediWound Announces Financial Results for Q3 2025 and Shares Corporate Developments
Nov 20 2025
Newsfilter
IGC Pharma, Inc. (IGC) Announces Q2 Loss and Falls Short of Revenue Projections
Nov 14 2025
NASDAQ.COM
MediWound Achieves Successful Commissioning of Enhanced GMP Manufacturing Facility for NexoBrid®
Nov 03 2025
Newsfilter
MediWound Launches $30 Million Registered Direct Offering; Stock Falls More Than 7%
Sep 29 2025
SeekingAlpha
MediWound Announces NexoBrid Receives Marketing Approval for Burn Treatment in Australia
Sep 25 2025
NASDAQ.COM
MediWound to Showcase at the 27th Annual Global Investment Conference Hosted by H.C. Wainwright
Aug 20 2025
Newsfilter
Show More News
